ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

PHAT Phathom Pharmaceuticals Inc

10,04
0,28 (2,87%)
Nach Börsenschluss
Zuletzt aktualisiert: 23:08:30
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Phathom Pharmaceuticals Inc PHAT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,28 2,87% 10,04 23:08:30
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
10,35 9,84 10,37 10,04 9,76
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
29.4.202414:00GLOBEPhathom Pharmaceuticals to Report First Quarter 2024..
03.4.202414:00GLOBEPhathom Pharmaceuticals to Participate in the 23rd Annual..
26.3.202413:00GLOBEPhathom Pharmaceuticals Launches Direct-to-Consumer..
07.3.202422:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07.3.202414:06EDGAR2Form 8-K - Current report
07.3.202414:00GLOBEPhathom Pharmaceuticals Reports Fourth Quarter and Full Year..
29.2.202414:00GLOBEPhathom Pharmaceuticals to Report Fourth Quarter and Full..
13.2.202414:05EDGAR2Form 8-K - Current report
13.2.202414:00GLOBEPhathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan)..
31.1.202414:00GLOBEPhathom Pharmaceuticals to Present at the Guggenheim..
23.1.202402:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.12.202322:05EDGAR2Form 8-K - Current report
14.12.202314:05EDGAR2Form 8-K - Current report
14.12.202314:00GLOBEPhathom Pharmaceuticals Announces Expansion of Existing Loan..
06.12.202314:05EDGAR2Form 8-K - Current report
06.12.202314:00GLOBEPhathom Pharmaceuticals Announces FDA Acceptance for Filing..
28.11.202314:06EDGAR2Form 8-K - Current report
28.11.202314:00GLOBEPhathom Pharmaceuticals Announces Commercial Availability of..
20.11.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
09.11.202322:02EDGAR2Form S-3 - Registration statement under Securities Act of..
09.11.202314:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202314:05EDGAR2Form 8-K - Current report
09.11.202314:00GLOBEPhathom Pharmaceuticals Reports Third Quarter 2023 Results..
09.11.202301:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.11.202321:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.11.202322:50DJNPhathom Pharmaceuticals Gets FDA Approval for Voquezna..
01.11.202322:06EDGAR2Form 8-K - Current report
01.11.202322:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of VOQUEZNA®..
30.10.202313:05EDGAR2Form 8-K - Current report
30.10.202313:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of..
25.10.202314:01GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
26.9.202314:05EDGAR2Form 8-K - Current report
26.9.202314:01GLOBEPhathom Pharmaceuticals Announces Vonoprazan NDA Submission..
05.9.202314:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
21.8.202314:07EDGAR2Form 8-K - Current report
21.8.202314:00GLOBEPhathom Pharmaceuticals Announces Submission of Six-Month..
10.8.202322:02EDGAR2Form 8-K - Current report
10.8.202314:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202314:01GLOBEPhathom Pharmaceuticals Reports Second Quarter 2023 Results
17.7.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.7.202322:04EDGAR2Form 8-K - Current report
17.7.202322:02EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
12.6.202315:04DJNFDA Accepts Phathom Pharmaceuticals' Resubmission for..
12.6.202314:01GLOBEPhathom Pharmaceuticals Announces FDA Acceptance of NDA..
09.6.202322:01GLOBEPhathom Pharmaceuticals Announces Closing of Underwriters’..
09.6.202311:45PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..
07.6.202311:45PRNUSINVESTIGATION ALERT: The Gross Law Firm Notifies..
02.6.202311:45PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..
01.6.202314:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
30.5.202311:00PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock